Share

    


In This Section

Advisory Committee

Multi-Cancer Early Detection Advisory Committee
Dr. Regina Jacob
Regina Jacob, MD, MSCE
Associate Professor, Clinical Medicine
The Lewis Katz School of Medicine – Temple University
Philadelphia, PA

Regina Jacob, MD, MSCE, is an associate professor of Clinical Medicine and director of the Social Determinants of Health Curriculum for the Internal Medicine Residency Program at the Lewis Katz School of Medicine at Temple University in North Philadelphia.  She is also the medical director of Temple Internal Medicine Associates. Her clinical interests include survivorship medicine for cancer survivors, post-traumatic stress disorder (PTSD), and post traumatic growth following a diagnosis of lymphoma. Her research interests.

Dr. Jacob has two main research interests which include assessing psychological adjustment and co-morbid medical conditions.  She conducted a study, Coping with Lymphoma to Enhance Adjustment and Reduce Stress, which assessed the psychological adjustments that may occur after a diagnosis of lymphoma.  Her second research interest involves assessing co-morbid conditions that result from chronic and cumulative trauma exposure.  She is currently conducting a study, Trauma Alert! How Social Complexity Contributes to Medical Complexity, which assesses the prevalence of post-traumatic stress disorder (PTSD), adverse childhood experiences, depression, and co-morbidity in an underserved primary care population. She also continues to grow her cancer survivorship expertise in education, designing curricula to educate internal medicine residents on how to appropriately tailor primary care for patients with a history of cancer.

Dr. Jabcob received her MD from The George Washington University in Washington, D.C., completed her internal medicine residency at Temple University Hospital, and earned a master’s degree in Clinical Epidemiology at The Weill Cornell Medical College of Cornell University in Manhattan, New York.

State of Multi-Cancer Early Detection Advisory Committee
Nabavizadeh_Nima-100x100
Nima Nabavizadeh, MD
Director of the Radiation Oncology Residency Program
Cancer Early Detection Clinical Research at CEDAR
Portland, OR

Dr. Nima Nabavizadeh MD is Associate Professor of radiation medicine, Program Director of the Radiation Oncology Residency Program for the Department of Radiation Medicine and Director of the Cancer Early Detection Clinical Research at CEDAR. Through partnerships with many biotech companies, Dr. Nabavizadeh studies the testing and implementation of novel tests for the early development of cancers. Clinically, he specializes in gastrointestinal oncology and lymphoma/hematologic malignancies, but treats all types of cancer. Dr. Nabavizadeh earned an undergraduate degree in Mechanical Engineering at the University of Oklahoma, where he also went to medical school. He completed his residency training in radiation oncology at OHSU.

ODonnell_Elizabeth-100x100
Elizabeth K. O'Donnell, MD
Director, Multi-Cancer Early Detection Clinic
Centers for Early Detection and Interception at the Dana-Farber Cancer Institute
Boston, MA

Dr. O’Donnell is a medical oncologist and the Director of the Multi-Cancer Early Detection Clinic in the Centers for Early Detection and Interception at the Dana-Farber Cancer Institute. She is an Assistant Professor of Medicine at Harvard Medical School and a physician-researcher in the Plasma Cell Disorder Center. She graduated from Vanderbilt Medical School and completed her residency at Beth Israel Deaconess Medical Center where she spent an additional year as a chief resident. She completed her fellowship in hematology and oncology at the Dana-Farber Cancer Institute. Her research focuses on early detection of cancer and therapeutic and lifestyle interventions for the treatment of plasma cell dyscrasias.

Our Partner

Cancer Support Community Logo